SCHEMBL7278965

SCHEMBL7278965

O=C(O)c1ccc(C(=O)NS(=O)(=O)c2ccccc2)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 3/20 0.65
FLT1 P17948 2/20 0.65
FLT4 P35916 2/20 0.65
KDR P35968 2/20 0.65
MEN1 O00255 2/20 0.65
KMT2A Q03164 2/20 0.65
LMNA P02545 1/20 0.65
L3MBTL1 Q9Y468 1/20 0.65
PTGS2 P35354 3/20 0.63
PTGS1 P23219 2/20 0.63
BCL2L1 Q07817 1/20 0.59
MCL1 Q07820 1/20 0.59
ALKBH2 Q6NS38 1/20 0.59
ALKBH5 Q6P6C2 1/20 0.59
FTO Q9C0B1 1/20 0.59
KDM4E B2RXH2 1/20 0.57
KAT6A Q92794 1/20 0.56
HPGD P15428 1/20 0.56
EGFR P00533 1/20 0.55
CA1 P00915 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8424044 0.95 FLT1 (0.73) P4HTMFLT1FLT4KDRMEN1
SCHEMBL5931288 0.94 FLT1 (0.71) P4HTMFLT1FLT4KDRMEN1
SCHEMBL174010 0.90 FLT1 (0.77) P4HTMFLT1FLT4KDRMEN1
SCHEMBL29011132 0.89 FLT1 (0.74) P4HTMFLT1FLT4KDRMEN1
Potassium SCHEMBL30358590 0.89 FLT1 (0.74) P4HTMFLT1FLT4KDRMEN1
SCHEMBL31331608 0.87 BCL2L1 (0.75) P4HTMFLT1FLT4KDRMEN1
SCHEMBL24347999 0.86 PTGS2 (0.67) P4HTMFLT1FLT4KDRMEN1
SCHEMBL12489988 0.86 MEN1 (0.66) P4HTMFLT1FLT4KDRMEN1
SCHEMBL8825440 0.86 FLT1 (0.61) P4HTMFLT1FLT4KDRMEN1
SCHEMBL8660071 0.86 MEN1 (0.87) P4HTMFLT1FLT4KDRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0291234-B1 Peptidic human leukocyte elastase (HLE) inhibitors ZENECA INC (US) 1994-03-23 EP disclosed
EP-0272671-B1 Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors SANDOZ LTD (CH) 1994-03-16 EP disclosed
US-5164371-A HETEROCYCLIC KETONES ICI AMERICAS INC. (US) 1992-11-17 US disclosed
US-5158936-A Treating or prevention of tissue damage, inflammation, bone resporpption and muscular dystrophy SYNTEX (U.S.A.) INC. (US) 1992-10-27 US disclosed
US-5055451-A Prevent tissue damage SYNTEX INC. (US) 1991-10-08 US disclosed
CN-1037519-A HETEROCYCLIC KETONES ICI AMERICA INC (US) 1989-11-29 CN disclosed
US-4880780-A RESPIRATORY SYSTEM DISORDERS ICI AMERICAS INC. (US) 1989-11-14 US disclosed
EP-0291234-A2 Peptidic human leukocyte elastase (HLE) inhibitors ZENECA INC. (US) 1988-11-17 EP disclosed
EP-0272671-A2 Aryloxy and arylacyloxy methyl ketones as thiol protease inhibitors SANDOZ LTD. (CH) 1988-06-29 EP disclosed